Carter brings a background in investigative journalism to the role, having spent years reporting on cartel activity and drug ...

James Kimmel, Jr., is a lecturer of psychiatry at the Yale School of Medicine, a lawyer, and the founder and co-director of the Yale Collaborative for Motive Control Studies. He is the creator of The ...

Illegal drugs fundamentally shaped the 2024 Presidential election. The campaign season helped to reignite a focus on the opioid crisis and its devastating impacts on communities across the country.

A drug called buprenorphine may be the best tool doctors have to fight the fentanyl crisis. Why hasn’t it been more widely adopted? A dose of buprenorphine, an opioid that can help treat addiction to ...

Ms. Szalavitz is a contributing Opinion writer who covers addiction and public policy. In late 2016, Steven Klein realized that he’d lost control over his drinking and stimulant use. He became sober ...

Are cookies and chips the new cigarettes? And soda, breakfast cereals and ice cream the new opioids? In his new book, “Diet, Drugs, and Dopamine: The New Science of Achieving a Healthy Weight” ...

What Is It Like To Be an Addict? Understanding Substance Abuse, by Owen Flanagan, Oxford University Press, 320 pages, $24.99 Addiction is a problem that defenders of liberty need to face, for if ...

Remarkable scientific progress over the past five decades has helped us develop knowledge of how drugs of abuse induce pleasure, reinforce use, and lead to the compulsive self-administration we call ...

Ana Clara Bobadilla receives funding from the National Institute on Drug Abuse and the Brain & Behavior Research Foundation. Everyday human behavior is guided and shaped by the search for rewards.

COPENHAGEN, March 6 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab will explore how GLP-1 drugs could help patients struggling with addiction, its head of development Martin Holst Lange told an ...

A study using Swedish patient data found anti-obesity drugs were linked with fewer hospitalizations related to alcohol use, adding to a body of work suggesting these drugs could potentially be used to ...

GLP-1 drugs, originally developed for diabetes and obesity, may also curb addictive behaviors by acting on reward circuits in the brain. Early trials show reductions in alcohol intake, opioid seeking, ...